
|Videos|January 11, 2023
2022 Society of Urologic Cancer Annual Meeting recap - SUO/YUO research highlight
Author(s)Urology Times staff
“The takeaway from that talk was that it's critically important to review drug plan options, particularly if the patient's on a high-cost drug,” says Kelly L. Stratton, MD, FACS.
Advertisement
In this video, Kelly L. Stratton, MD, FACS, recaps a presentation from the 2022 Society of Urologic Oncology Annual Meeting Young Urologic Oncologists Program regarding cost savings for prostate cancer treatments. Stratton is an assistant professor of urologic oncology at the University of Oklahoma, Oklahoma City.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5










